retatrutide ly3437943 glp-1 gip glucagon receptor agonist Glucagon-like peptide-1 receptor: mechanisms and advances in therapy The Effects of Dual GLP-1/GIP

Inflammation in atherosclerosis: from pathophysiology to practice

The LEADER (Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results) trial was a pivotal milestone as it showed the cardiovascular benefits of liraglutide in patients with T2D and high cardiovascular risk

This degree of glucose lowering often enables patients to achieve their individualised HbA1c targets as recommended by NICE (typically 48 mmol/mol for most adults with type 2 diabetes, or 53 mmol/mol for those at risk of hypoglycaemia)

Source: University of Bristol Image Credit: iStock

Educated at Belfast Model School, Moore did evening courses at Belfast Working Men's Institute in order to get the necessary qualifications to study at Queen's College Belfast

It can make evidence-based medical weight-loss treatment more accessible and more practical than before